Gastric cancer chemotherapy
Material and methods: A retrospective study was carried out on gastric cancer chemotherapy of patients admitted in gastric cancer chemotherapy period June - March The gastric cancer chemotherapy of hospitalization was between 1 and 61 days, with an average of The data from observation files, the operating protocols, pathology reports and follow-up files were collected and analyzed. The most common complication was septic shock and mortality was 9.
Average survival was 5. Conclusion: PC-GI is a disease with a poor prognosis, posing difficulties in early diagnosis, establishing the surgical indication and protocol.
Case Discussions: Neo-adjuvant/Adjuvant treatment in gastric cancer: Optimal approach in 2017?
Consistent advances in systemic and locoregional chemotherapy, surgical techniques, intraoperative radiotherapy, as well as immunotherapy are expected to improve prognosis. Author Biographies I.
Deschisă înîn România, Amethyst Radiotherapy s-a dezvoltat rapid, devenind în 2 ani cea mai extinsă reţea paneuropeană de centre dedicate tratamentului cancerului prin radioterapie. În prezent, reţeaua Amethyst are 6 clinici deschise în 4 ţări, cumulând 10 acceleratoare liniare şi 4 echipamente de brahiterapie.
Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future. J Surg Oncol ; Prognostic significance of tumor markers in peritoneal lavage in gastric cancer chemotherapy gastric cancer.
Oncology ; Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative gastric cancer chemotherapy and evaluation of interobserver agreement.
Nucl Med Commun ; Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
J Clin Oncol ; Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination gastric cancer chemotherapy appendiceal mucinous malignancy.
Ann Surg Oncol ; Cost of an intraperitoneal chemohyperthermia IPCH related to cytoreductive surgery. Ann Chir ; Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy HIPEC.
Combined surgery, chemotherapy, and radiotherapy improved survival, but the side effects and the poor performance status of the patients seriously affect the use of these methods. Isorel is aqueous extract well known for its anticancer gastric cancer chemotherapy obtained by various in vitro and in vivo experimental models and which was validated by an in vitro bioassay on murine melanoma B16F10 and human cervical carcinoma HeLa cells. Hence, it was further used in a prospective, randomized, and controlled study which compared the postoperative results for patients with colorectal cancer stages Dukes C 40 patients and D 24 patients who, beside surgery, received either only chemotherapy 5-FU6 cycles either the Mayo or the De Gramont protocol or chemotherapy combined with Isorel biotherapy. We noted no toxic deaths due to either chemo or gastric cancer chemotherapy.
Eur J Surg Oncol ; Onkologie ; Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. J BUON ; Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?
Ann Surg ; Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy IHPC : postoperative morbidity and mortality and short-term follow-up. Ann Ital Chir ;